YAP1 and neoplasm: Pharmacologic inhibition of YAP1 specifically reduced CSC-like properties and suppressed tumor growth in YAP1high PC cells, especially in combination with cytotoxic agents in an in vivo patient-derived xenograft (PDX) model [124].